KR20190076829A - Oral composition and method for inhibiting discoloration thereof - Google Patents

Oral composition and method for inhibiting discoloration thereof Download PDF

Info

Publication number
KR20190076829A
KR20190076829A KR1020180112642A KR20180112642A KR20190076829A KR 20190076829 A KR20190076829 A KR 20190076829A KR 1020180112642 A KR1020180112642 A KR 1020180112642A KR 20180112642 A KR20180112642 A KR 20180112642A KR 20190076829 A KR20190076829 A KR 20190076829A
Authority
KR
South Korea
Prior art keywords
oral composition
composition
discoloration
component
mass
Prior art date
Application number
KR1020180112642A
Other languages
Korean (ko)
Other versions
KR102531788B1 (en
Inventor
케이지 이시구로
고우타로우 이이즈미
Original Assignee
라이온 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라이온 가부시키가이샤 filed Critical 라이온 가부시키가이샤
Publication of KR20190076829A publication Critical patent/KR20190076829A/en
Application granted granted Critical
Publication of KR102531788B1 publication Critical patent/KR102531788B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/411Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to an oral composition containing tranexamic acid with suppressed preparation discoloration even after high temperature storage and excellent appearance stability, and a method for inhibiting discoloration thereof. The oral composition comprises (A) tranexamic acid, (B) cationized cellulose, and (C) tea extract, in which [(A)+(B)]/(C) is 0.5 to 200 as mass ratio, and (B)/(C) is 0.2 to 100 as mass ratio. The oral composition further comprises (D) at least one selected from 3-octanol, 3-octyl acetate, 3-octanone, and fenchone. The method for inhibiting discoloration of the oral composition mixes the (C) component in the oral composition mixed with the (A) and (B) components, in which the mass ratio of [(A)+(B)]/(C) and the mass ratio of (B)/(C) are each within the above range.

Description

구강용 조성물 및 그 변색 억제 방법{ORAL COMPOSITION AND METHOD FOR INHIBITING DISCOLORATION THEREOF}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for oral use and a method for inhibiting discoloration thereof,

본 발명은, 고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 갖는 트라넥삼산 함유의 구강용 조성물 및 그 변색 억제 방법에 관한 것이다.The present invention relates to a composition for oral use containing tranexamic acid and a method for inhibiting discoloration thereof, the composition being discolored even after storage at high temperature and having excellent appearance stability.

트라넥삼산은, 잇몸의 항염증 효과가 있는 기능 성분이고, 치주병 예방 성분으로서 구강용 조성물에 배합되고(특허 문헌 1 ; 일본 특개2009-149565호 공보), 치마제 조성물에 배합한 트라넥삼산의 구강 내 체류성을 개선하여 효과를 향상하기 위해 히드록시에틸셀룰로스·디메틸디알릴암모늄염이 효과를 이루는 것이, 특허 문헌 2(일본 특개2001-226244호 공보)에 제안되어 있다.Tranexamic acid is a functional ingredient having an anti-inflammatory effect of the gum, and is incorporated in an oral composition as a periodontal disease preventing ingredient (Patent Document 1: Japanese Patent Laid-Open Publication No. 2009-149565), and tranexamic acid Patent Document 2 (Japanese Patent Application Laid-Open No. 2001-226244) proposes that a hydroxyethyl cellulose dimethyldiallylammonium salt is effective for improving the retention in the mouth and improving the effect.

또한, 트라넥삼산은, 구강용 조성물의 사용감 개선에 응용할 수 있는 것이 특허 문헌 3, 4(일본 특개2008-143870호 공보, 일본 특개소60-130509호 공보)에 제안되어 있다.In addition, tranexamic acid has been proposed in Patent Documents 3 and 4 (Japanese Patent Application Laid-Open No. 2008-143870 and Japanese Patent Application Laid-open No. 60-130509) that can be applied to improvement of feeling on use of oral compositions.

그렇지만, 트라넥삼산은, 배합 성분에 의해서는 경시에서 제제 변색을 초래하는 일이 있다는 문제가 있다. 변색을 억제하는 기술은, 특허 문헌 5, 6(일본 특허 제4656299호 공보, 일본 특허 제5842565호 공보)에 제안되어 있고, 특허 문헌 6에서는, 세구제에 트라넥삼산과 향료 성분인 신나믹알데히드를 병용하여 배합함으로써 생기는 경시에서의 제제 변색의 억제에, 라우릴황산나트륨을 특정량 배합하여 외관 안정성을 개선하고 있다.However, there is a problem that in the case of tranexamic acid, the coloring of the preparation may occur with time depending on the components to be mixed. Patent Literatures 5 and 6 (Japanese Patent No. 4656299 and Japanese Patent No. 5842565) disclose a technique for suppressing discoloration. Patent Document 6 discloses a technique in which trinne triacane and cinnamic aldehyde In combination with a specific amount of sodium lauryl sulfate to suppress discoloration of the formulation over time, thereby improving the appearance stability.

특허 문헌 1 : 일본 특개2009-149565호 공보Patent Document 1: JP-A-2009-149565 특허 문헌 2 : 일본 특개2001-226244호 공보Patent Document 2: JP-A-2001-226244 특허 문헌 3 : 일본 특개2008-143870호 공보Patent Document 3: Japanese Patent Application Laid-Open No. 2008-143870 특허 문헌 4 : 일본 특개소60-130509호 공보Patent Document 4: Japanese Patent Application Laid-Open No. 60-130509 특허 문헌 5 : 일본 특허 제4656299호 공보Patent Document 5: Japanese Patent No. 4656299 특허 문헌 6 : 일본 특허 제5842565호 공보Patent Document 6: Japanese Patent No. 5842565

본 발명은 상기 사정을 감안하여 이루어진 것으로, 고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 주는 트라넥삼산 함유의 구강용 조성물 및 그 변색 억제 방법을 제공하는 것을 목적으로 한다.The present invention has been made in view of the above circumstances, and it is an object of the present invention to provide an oral composition containing tranexamic acid and a method for inhibiting discoloration thereof, which can suppress discoloration of a preparation even after preservation at a high temperature and provide excellent appearance stability.

본 발명자들은, 상기 목적을 달성하기 위해 예의 검토를 행한 결과, 구강용 조성물에 트라넥삼산과 카티온화셀룰로스를 배합한 때에 생기는 제제 변색의 억제에, 차엑기스를 특정 비율로 배합하는 것이 유효한 것을 지견하였다. 즉, 본 발명에서는, (A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비가 각각 특정 범위 내인 것에 의해, 고온 보존 후에도 제제 변색이 억제되고, 우수한 외관 안정성을 주고, 또한, 불쾌한 맛이 억제되어 맛이 좋은 사용감을 주는 구강용 조성물을 제공할 수 있는 것을 지견하여, 본 발명을 이루는데 이르렀다.The inventors of the present invention have conducted intensive studies in order to achieve the above object and as a result, it has been found that it is effective to blend tea extracts at a specific ratio in inhibiting discoloration of a preparation caused by blending of tranexamic acid and cationic cellulose in an oral composition Respectively. That is, in the present invention, (C) tea extract is compounded in an oral composition containing (A) a tranexamic acid and (B) (B) / (C) within a specific range, it is possible to provide a composition for oral cavity which suppresses discoloration of a preparation even after preservation at high temperature, gives excellent appearance stability and suppresses unpleasant taste, The present invention has been accomplished.

더욱 상세히 기술하면, 상술한 바와 같이, 치마제 조성물에서의 트라넥삼산의 구강 내 체류성의 향상에 카티온화셀룰로스의 히드록시에틸셀룰로스·디메틸디알릴암모늄염이 유효한 것은 알려져 있지(특허 문헌 2)만, 본 발명자들이, (A) 트라넥삼산에, 구강 내 체류성을 개선하기 위해 (B) 카티온화셀룰로스를 병용하여 구강용 조성물에 배합한 바, 고온 보존 후에 갈변이 발생하여 제제가 변색한다는 과제가 생기고, 게다가, 상기한 갈변에 의한 제제 변색은, 셀룰로스 유도체라도 카르복시메틸셀룰로스나트륨을 사용한 때에는 인정되지 않고, (A) 및 (B)성분을 병용한 때에 생기는 독특한 과제인 것도 알았다. 그래서 본 발명자들은, 이러한 과제를 해결하기 위해 검토를 진행한 결과, (A) 및 (B)성분의 병용계에 (C)성분을 조합시키면, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비가 각각 특정 범위 내에서 (C)성분이 특이적으로 작용하여, 상기 병용계에 의한 제제 변색이 억제되고, 이에 의해, 고온 보존 후도 제제 변색이 억제되어 우수한 외관 안정성을 줄 수가 있었다. 또한, 이 경우, (A) 및 (B)성분을 병용하면 사용 후의 구강 내에 독특한 불쾌한 맛이 남는 일이 있지만, 이 불쾌한 맛의 뒷맛도 (C)성분에 의해 개선하고, 상기 각별히 현저한 작용 효과를 부여할 수 있었다.More specifically, as described above, it is not known that the hydroxyethyl cellulose-dimethyldiallylammonium salt of cationic cellulose is effective for improving retention of tranexamic acid in the oral cavity in the dentifrice composition (Patent Document 2) The inventors of the present invention have found that (A) tranexamic acid is blended with an oral composition in combination with (C) cationic cellulose to improve retention in the oral cavity, and the problem that browning occurs after storage at high temperature, Furthermore, it has also been found that the above-mentioned discoloration of the preparation due to browning is not recognized when sodium carboxymethyl cellulose is used as the cellulose derivative, and is a unique problem to be caused when the components (A) and (B) are used in combination. (A) + (B)] / (C) by combining the component (C) with the combination system of the components (A) and (B). As a result, Component (C) specifically acts within a specific range of the mass ratio of (B) / (C), thereby suppressing discoloration of the preparation by the combination system, So that excellent appearance stability could be obtained. In this case, when the components (A) and (B) are used in combination in this case, unpleasant tastes unique to the mouth may remain after use, but the aftertaste of this unpleasant taste is also improved by the component (C) .

후술하는 비교례의 결과로부터도 분명한 바와 같이, 본 발명의 작용 효과는, (A), (B) 및 (C)성분을 조합시켜서 사용하여도, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비의 어느 하나가 부적절하면 뒤떨어지고, 또한, (A) 및 (B)성분에, (C)성분에 대신하여, 차엑기스와 마찬가지로 항산화작용을 갖는 식물 추출물인 감초엑기스를 조합시켜서 사용한 경우에는, 뒤떨어지는 것이었다.(A) + (B)] / (C), even when the components (A), (B) and (C) are used in combination, the effect of the present invention ) And the mass ratio of (B) / (C) is inadequate, and in addition to the components (A) and (B) When the licorice extract, which is a plant extract, was used in combination, it was inferior.

또한, 특허 문헌 2의 치마제 조성물은, 트라넥삼산 및 아니온성 계면활성제와 함께 히드록시에틸셀룰로스·디메틸디알릴암모늄염과, 아네톨, 카르본, 시네올, 메틸살리실레이트, 오이게놀, 에틸부틸레이트 및 신나믹알데히드에서 선택되는 특정한 향료 성분을 함유하고, 트라넥삼산의 구강 내 체류성 및 보존 안정성(액 분리)이 향상하고 있다. 이에 대해, 본 발명의 (A), (B) 및 (C)성분을 함유하는 구강용 조성물은, 상기 특정한 향료 성분을 함유하지 않아도, (A)성분에 의한 제제 변색이 억제되어 고온 보존 후도 외관 안정성(변색)이 우수하고, 맛도 좋다.In addition, the dentifrice composition of Patent Document 2 contains hydroxyethyl cellulose dimethyldiallylammonium salt together with tranexamic acid and anionic surfactant and anionic surfactant such as anethole, carbone, cineol, methyl salicylate, Ethyl butyrate and cinnamic aldehyde, and the retention properties and storage stability (liquid separation) of tranexamic acid in oral cavity are improved. On the other hand, in the oral composition containing the components (A), (B) and (C) of the present invention, the composition discoloration due to the component (A) is suppressed even after the above- Excellent appearance stability (discoloration) and good taste.

따라서 본 발명은, 하기한 구강용 조성물 및 그 변색 억제 방법을 제공한다.Accordingly, the present invention provides the following composition for oral use and a method for suppressing discoloration thereof.

[1] (A) 트라넥삼산,[1] (A) Tranexamic acid,

(B) 카티온화셀룰로스 및(B) cationic cellulose and

(C) 차엑기스를 함유하고, [(A)+(B)]/(C)가 질량비로서 0.5∼200, 또한 (B)/(C)가 질량비로서 0.2∼100인 것을 특징으로 하는 구강용 조성물.(B) / (C) is in a mass ratio of 0.5 to 200, and (B) / (C) is in a mass ratio of 0.2 to 100, Composition.

[2] (B) 카티온화셀룰로스가, 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드인 [1]에 기재된 구강용 조성물.[2] The oral composition according to [1], wherein the cationic cellulose (B) is hydroxyethyl cellulose dimethyldiallylammonium chloride.

[3] (A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 엑기스 순분으로서 0.0005∼0.2질량% 함유하는 [1] 또는 [2]에 기재된 구강용 조성물.[3] The oral cavity according to [1] or [2], which contains 0.01 to 0.2% by mass of the component (A), 0.01 to 0.2% by mass of the component (B), and 0.0005 to 0.2% by mass of the component (C) / RTI >

[4] 또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 이상을 0.0001∼0.1질량% 함유하는 [1]∼[3]의 어느 하나에 기재된 구강용 조성물.[4] The composition according to any one of [1] to [3], which further comprises 0.0001 to 0.1% by mass of at least one selected from the group consisting of 3-octanol, 3-octyl acetate, Oral composition.

[5] 치마제 또는 세구제인 [1]∼[4]의 어느 하나에 기재된 구강용 조성물.[5] The oral composition according to any one of [1] to [4], which is a skirt or a remedy.

[6] (A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)를 질량비로서 0.5∼200, 또한 (B)/(C)를 질량비로서 0.2∼100으로 하는 것을 특징으로 하는, 상기 구강용 조성물의 변색 억제 방법.(C) tea extract is added to an oral composition containing (A) tranexamic acid and (B) cationic cellulose, and the ratio of [(A) + (B)] / (C) To 200, and (B) / (C) in a mass ratio of 0.2 to 100.

[7] (A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 엑기스 순분으로서 0.0005∼0.2질량%배합하는, [6]에 기재된 상기 구강용 조성물의 변색 억제 방법.[7] The oral composition according to [6], wherein the composition for oral cavity according to [6], which comprises 0.01 to 0.2 mass% of component (A), 0.01 to 0.2 mass% of component (B), and 0.0005 to 0.2 mass% / RTI >

본 발명에 의하면, 고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 주고, 또한, 불쾌한 맛이 억제되어 맛이 좋은 사용감을 주는 트라넥삼산 함유의 구강용 조성물을 제공할 수 있다. 본 발명의 구강용 조성물은, 트라넥삼산의 구강 내 체류성도 좋고, 항염증 효과를 기대할 수 있는 것이어서 치육염을 억제하는 잇몸 케어용으로 적합하다.According to the present invention, it is possible to provide a composition for oral care containing tranexamic acid, which is capable of suppressing discoloration of the preparation even after storage at a high temperature, imparting excellent appearance stability, and suppressing unpleasant taste and providing a pleasant taste. The composition for oral use of the present invention is suitable for gingival care which suppresses the oral gingivitis because of its excellent retention in the oral cavity of the tranexamic acid and anti-inflammatory effect.

이하, 본 발명에 대해 더욱 상세히 기술한다. 본 발명의 구강용 조성물은, (A) 트라넥삼산, (B) 카티온화셀룰로스 및 (C) 차엑기스를 함유한다.Hereinafter, the present invention will be described in more detail. The oral composition of the present invention contains (A) tranexamic acid, (B) cationic cellulose and (C) tea extract.

(A) 트라넥삼산은, 유효 성분이고, 항염증 작용을 갖는다. (A) 트라넥삼산의 배합량은, 조성물 전체의 0.01∼0.2%(질량%, 이하 마찬가지)가 바람직하고, 특히 항염증 효과 및 변색 억제의 점에서 0.03∼0.1%가 보다 바람직하다. 이 범위 내이면, 제제 변색이 충분히 억제되고, 또한, 불쾌한 맛을 충분히 개선한다.(A) Tranexamic acid is an effective ingredient and has an anti-inflammatory action. The blending amount of (A) tranexamic acid is preferably 0.01 to 0.2% (mass%, the same applies hereinafter) of the whole composition, more preferably 0.03 to 0.1% from the viewpoint of anti-inflammatory effect and discoloration inhibition. Within this range, the discoloration of the preparation is sufficiently inhibited, and the unpleasant taste is sufficiently improved.

(B) 카티온화셀룰로스는, (A)성분의 구강 내 체류성을 향상하는 작용을 갖는다. (B) 카티온화셀룰로스로서는, 카티온기로서 디메틸디알릴암모늄, 2-히드록시-3(트리메틸암모니오)프로필 등을, 셀룰로스 유도체에 부가한 것 등을 들 수 있다. 예를 들면, 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드, 염화O-[2-히드록시-3-(트리메틸암모니오)프로필]히드록시에틸셀룰로스 등이다. 질소 함유량은 0.1∼3%가 바람직하고, 보다 바람직하게는 0.5∼2. 5%이다.(B) Cationic cellulose has an effect of improving the retention of the component (A) in the oral cavity. Examples of the cationic cellulose (B) include dimethyldiallylammonium, 2-hydroxy-3 (trimethylammonio) propyl and the like added as a cationizing agent to a cellulose derivative. For example, hydroxyethyl cellulose dimethyldiallylammonium chloride, chlorinated O- [2-hydroxy-3- (trimethylammonio) propyl] hydroxyethyl cellulose, and the like. The nitrogen content is preferably from 0.1 to 3%, more preferably from 0.5 to 2%. 5%.

구체적으로 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드는, 히드록시에틸셀룰로스에 디메틸디알릴암모늄염을 그라프트 중합한 것이고, 2% 수용액의 점도가 10∼3,000mPa·s의 것(BH형 브룩필드 점도계, 로터 No. 2, 20회전, 21℃)을 사용할 수 있다. 예를 들면, 악조노벨(주)제의 셀코트 L-200(2% 수용액 점도 : 35∼350mPa·s, BH형 브룩필드 점도계, 로터 No. 2, 20회전, 21℃, 측정시간 1분), 셀코트 H-100(2% 수용액 점도 : 500∼2,750mPa·s, BH형 브룩필드 점도계, 로터 No. 2, 20회전, 21℃, 측정시간 1분) 등을 들 수 있다.Specifically, hydroxyethyl cellulose dimethyldiallylammonium chloride is a product obtained by graft-polymerizing dimethyldiallylammonium salt on hydroxyethyl cellulose, and having a viscosity of 10 to 3,000 mPa · s in a 2% aqueous solution (BH Brookfield viscometer , Rotor No. 2, 20 revolutions, 21 캜) can be used. For example, Cellcoat L-200 (2% aqueous solution viscosity: 35 to 350 mPa s, BH Brookfield viscometer, rotor No. 2, 20 revolutions, 21 캜, measuring time 1 minute) manufactured by Akzo Nobel Co., , Cell coat H-100 (viscosity of 2% aqueous solution: 500 to 2,750 mPa 揃 s, BH type Brookfield viscometer, rotor No. 2, 20 revolutions, 21 캜, measuring time of 1 minute).

또한, 염화O-[2-히드록시-3-(트리메틸암모니오)프로필]히드록시에틸셀룰로스는, 1% 또는 2% 수용액으로 점도 측정을 할 수 있고, 1% 수용액의 점도가 500∼2,600mPa·s(BH형 브룩필드 점도계, 로터 No. 2, 20회전, 25℃)의 것, 또는 2% 수용액의 점도가 5∼800mPa·s의 것(BL형 점도계, 로터 No. 2, 30회전, 25℃)을 사용할 수 있다. 예를 들면, 라이온(주)제의 레오가드KGP(2% 수용액 점도 : 5∼50mPa·s), 레오가드G(2% 수용액 점도 : 100∼600mPa·s), 레오가드GP(2% 수용액 점도 : 100∼600mPa·s), 레오가드LP(2% 수용액 점도 : 300∼800mPa·s), 라이온(주)제의 레오가드MGP(1% 수용액 점도 : 500∼1, 200mPa·s), 레오가드㎖P(1% 수용액 점도 : 1,000∼2, 600mPa·s) 등을 들 수 있다.The viscosity of O- [2-hydroxy-3- (trimethylammonio) propyl] hydroxyethylcellulose chloride can be measured with a 1% or 2% aqueous solution and a viscosity of 1% aqueous solution of 500 to 2,600 mPa (BH type Brookfield viscometer, rotor No. 2, 20 revolutions, 25 캜) or a 2% aqueous solution having a viscosity of 5 to 800 mPa ((BL type viscometer, rotor No. 2, 25 DEG C) can be used. For example, Leogard KGP (2% aqueous solution viscosity: 5 to 50 mPa.s), Leogard G (2% aqueous solution viscosity: 100 to 600 mPa.s) : Leogard LP (2% aqueous solution viscosity: 300 to 800 mPa.s), Leogard MGP (1% aqueous solution viscosity: 500 to 1, 200 mPa.s) manufactured by Lion Corp., (Viscosity of 1% aqueous solution: 1,000 to 2, 600 mPa s), and the like.

이들 카티온화셀룰로스 중에서도, 특히 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드가, (A) 트라넥삼산의 구강 내 체류 성향상의 점에서 알맞다.Among these cationic cellulose, particularly hydroxyethyl cellulose dimethyldiallylammonium chloride is suitable in view of the retention tendency of (A) tranexamic acid in the mouth.

(B) 카티온화셀룰로스의 배합량은, 제제 변색 및 불쾌한 맛의 억제 효과의 점에서 조성물 전체의 0.01∼0.2%가 바람직하고, 0.03∼0.1%가 보다 바람직하다. 이 범위 내이면, 제제 변색이 충분히 억제되고, 또한, 불쾌한 맛이 충분히 개선한다. 0.2%를 초과하면, 그것 자신에 의한 불쾌한 맛이 강해져서 불쾌한 맛의 개선 효과가 충분히 얻어지지 않는 경우가 있다.The blending amount of the (C) cationic cellulose is preferably 0.01 to 0.2%, more preferably 0.03 to 0.1%, from the viewpoint of the effect of discoloring the preparation and suppressing the unpleasant taste. Within this range, the discoloration of the preparation is sufficiently inhibited, and the unpleasant taste is sufficiently improved. If it exceeds 0.2%, the unpleasant taste by itself becomes strong, and the effect of improving the unpleasant taste may not be sufficiently obtained.

본 발명에서는, (C) 차엑기스가, 제제 변색의 억제제로서 작용하고, 또한, 불쾌한 맛의 개선제로서도 작용한다.In the present invention, (C) tea extract acts as an inhibitor of discoloration of the preparation and also serves as an improper agent for improving taste.

C) 차엑기스는, 시판품 또는 공지의 방법에 의해 얻어진 것을 사용할 수 있다. 구체적으로 원료는, 녹차를 사용할 수 있다. 추출 용매는 친수성 용매를 사용할 수 있고, 물이나, 에탄올, 프로판올 등의 저급 1가 알코올, 1,3-부틸렌글리콜, 프로필렌글리콜 등의 다가 알코올 등의 친수성 용매를 들 수 있고, 이들에서 선택되는 1종의 단독 용매 또는 2종 이상의 혼합 용매를 사용할 수 있다. 추출 조건, 후처리는 통상의 방법을 채용할 수 있다.C) The tea extract may be a commercially available product or a product obtained by a known method. Specifically, green tea can be used as a raw material. As the extraction solvent, a hydrophilic solvent can be used, and examples thereof include water, hydrophilic solvents such as lower monohydric alcohols such as ethanol and propanol, and polyhydric alcohols such as 1,3-butylene glycol and propylene glycol. One kind of a single solvent or a mixed solvent of two or more kinds can be used. The extraction conditions and the post-treatment can be carried out by conventional methods.

시판품으로서는, 녹차 추출물(상품명 「화ism」, 엑기스분 0.2%, 용매 : 50%부틸렌글리콜 수용액, 마루젠제약(주)제) 등을 사용할 수 있다.As a commercially available product, green tea extract (trade name: "may ism", 0.2% of extract, solvent: 50% of butylene glycol aqueous solution, manufactured by Maruzen Pharmaceutical Co., Ltd.) can be used.

(C) 차엑기스의 배합량은, 용매를 제외한 엑기스 순분으로서 조성물 전체의 0.0005∼0.2%가 바람직하고, 보다 바람직하게는 0.001∼0.1%이다. 0.0005% 이상이면, 제제 변색이 충분히 억제되어 우수한 외관 안정성을 얻을 수 있고, 또한, 불쾌한 맛이 충분히 억제되고, 맛이 개선한다. 0.2% 이하면, (C)성분 자신의 맛의 영향을 충분히 방지할 수 있다.The blending amount of the tea extract (C) is preferably 0.0005 to 0.2%, more preferably 0.001 to 0.1%, of the entire composition as the pure extract of the extract excluding the solvent. When the amount is more than 0.0005%, the discoloration of the preparation is sufficiently inhibited to obtain excellent appearance stability, the unpleasant taste is suppressed sufficiently, and the taste is improved. If it is 0.2% or less, the influence of the taste of the component (C) itself can be sufficiently prevented.

본 발명에서 (A) 및 (B)성분의 배합량과 (C)성분의 배합량(용매를 제외한 엑기스 순분량)과의 비율을 나타내는 [(A)+(B)]/(C)는, 질량비로서 0.5∼200이고, 바람직하게는 1∼100이다. [(A)+(B)]/(C)의 질량비가 0.5 미만이면, (C)성분 자신의 맛에 의해 사용감이 손상되고, 200을 초과하면, 제제 변색의 억제 효과 및 불쾌한 맛의 개선 효과가 뒤떨어진다.In the present invention, [(A) + (B)] / (C), which represents the ratio of the blending amount of the components (A) and (B) to the blending amount of the component (C) 0.5 to 200, and preferably 1 to 100. If the mass ratio of [(A) + (B)] / (C) is less than 0.5, the feeling of use is impaired by the taste of the component (C) itself, and if it exceeds 200, .

또한, (B)성분의 배합량과 (C)성분의 배합량(용매를 제외한 엑기스 순분량)과의 비율을 나타내는 (B)/(C)는, 질량비로서 0.2∼100이고, 바람직하게는 0.5∼50이다. (B)/(C)의 질량비가 0.2 미만이면, (C)성분 자신의 맛에 의해 사용감이 손상된다. 100을 초과하면, 불쾌한 맛의 개선 효과가 뒤떨어진다.(B) / (C) representing the ratio of the blending amount of the component (B) to the blending amount of the component (C) (the amount of the extracted extract excluding the solvent) is 0.2 to 100 in mass ratio, to be. If the mass ratio of (B) / (C) is less than 0.2, the feeling of use is impaired by the taste of the component (C) itself. If it exceeds 100, the effect of improving the unpleasant taste is inferior.

본 발명에서는, 또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 또는 2종 이상의 향료 성분을 배합하는 것이 바람직하다. (C)성분과 함께 (D)성분을 배합하면, 불쾌한 맛의 개선 효과가 높아지고, 불쾌한 맛의 뒷맛을 보다 개선할 수 있다. 또한, 옥탄올이라도, 치마제 조성물의 향료로서 일반적인 1-옥탄올은, 목적으로 하는 불쾌한 맛의 개선 효과가 만족하게 얻어지지 않는다. (D)성분은, 시판품을 사용할 수 있다. 예를 들면, 3-옥탄올은 시오노향료(주)제, 3-옥틸아세테이트 및 3-옥탄온은 각각 (주)이노우에 향료제조소제, 펜콘은 코에이흥업(주)제의 제품을 사용할 수 있다.In the present invention, it is also preferable to incorporate one or more perfume ingredients selected from (D) 3-octanol, 3-octyl acetate, 3-octanone and fencone. When the component (D) is mixed with the component (C), the effect of improving the unpleasant taste is enhanced, and the aftertaste of the unpleasant taste can be further improved. Even with octanol, general 1-octanol as a flavoring agent for a dentifrice composition can not satisfactorily satisfy the object of improving the unpleasant taste. As the component (D), commercially available products can be used. For example, 3-octanol may be manufactured by Shiono Perfume Co., Ltd., 3-octyl acetate and 3-octanone may be manufactured by Inoue Flavor Manufacture Co., Ltd., and Pencon may be manufactured by Koei Kogyo Co., .

(D)성분의 배합량은, 0.0001∼0.1%가 바람직하고, 보다 바람직하게는 0.0001∼0.05%이다. 0.0001% 이상이면, 불쾌한 맛의 개선 효과가 충분히 향상한다. 0.1% 이하면, (D)성분 자체의 불쾌한 맛의 발현을 충분히 방지할 수 있다. (D)성분은, 총 배합량이 상기 범위 내인 것이 바람직하고, 이 범위 내에서 각 성분을 배합할 수 있다.The blending amount of the component (D) is preferably 0.0001 to 0.1%, more preferably 0.0001 to 0.05%. If it is 0.0001% or more, the effect of improving the unpleasant taste is sufficiently improved. If it is less than 0.1%, the unpleasant taste of the component (D) itself can be sufficiently prevented from being expressed. The total amount of the component (D) is preferably within the above range, and each component can be compounded within this range.

본 발명의 구강용 조성물은, 특히, 련치마, 액상치마, 윤제치마 등의 치마제, 특히 련치마나, 세구제로서 조제하는 것이 바람직하다. 또한, 상기 필수 성분에 더하여, 임의 성분으로서 제형 등에 응한 그 밖의 공지의 첨가제를, 본 발명의 효과를 방해하지 않는 범위에서 배합할 수 있다. 예를 들면 련치마인 경우는, 연마제, 점조제, 점결제, 계면활성제, 나아가서는 필요에 응하여 감미제, 방부제, 유효 성분, 착색제, 향료 등을 배합할 수 있고, 이들 성분과 물을 혼합하여 통상의 방법으로 제조할 수 있다. 세구제의 경우는, 점조제, 점결제, 계면활성제, 나아가서는 필요에 응하여 감미제, 방부제, 착색제, 향료, 유효 성분 등을 배합할 수 있다.The oral composition of the present invention is particularly preferably prepared as a dentifrice such as a continuous skirt, a liquid skirt, a skimmed skirt, especially a continuous skirt, or a mouthwash. Further, in addition to the above-mentioned essential components, other known additives, which are given as optional ingredients in accordance with the formulation and the like, may be compounded in such a range as not to interfere with the effect of the present invention. For example, in the case of a continuous skirt, a sweetener, an antiseptic, an effective ingredient, a coloring agent, a perfume, and the like may be blended in accordance with an abrasive, a tackifier, a binder, a surfactant, ≪ / RTI > In the case of a detergent, a sweetening agent, a preservative, a coloring agent, a flavoring agent, an effective ingredient, and the like may be compounded in accordance with a viscous agent, a binder, a surfactant, and furthermore, a necessity.

연마제로서는, 무수규산, 실리카겔, 알루미노실리케이트, 지르코노실리케이트 등의 실리카계 연마제, 제2인산칼슘2수화물, 제2인산칼슘무수화물, 제3인산칼슘, 제4인산칼슘, 제8인산칼슘, 피로인산칼슘, 수산화알루미늄, 알루미나, 2산화티탄, 결정성 지르코늄실리케이트, 폴리메틸메타아크릴레이트, 불용성 메타인산칼슘, 경질 탄산칼슘, 중질 탄산칼슘, 탄산마그네슘, 제3인산마그네슘, 제올라이트, 규산지르코늄, 하이드록시아파타이트, 플루오로아파타이트, 칼슘 결손 아파타이트, 합성수지계 연마제를 들 수 있다(배합량은 통상, 2∼50%, 특히 10∼40%).Examples of the abrasive include silica-based abrasives such as silicic anhydride, silica gel, aluminosilicate, and zirconosilicate, calcium secondary diborate dihydrate, calcium secondary diborate anhydride, calcium tertiary phosphate, calcium diphosphate, Magnesium carbonate, magnesium carbonate, zeolite, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, zirconium silicate, Hydroxyapatite, fluoroapatite, calcium-deficient apatite, and synthetic resin-based abrasive (blended amount is usually 2 to 50%, particularly 10 to 40%).

점조제로서는, 글리세린, 프로필렌글리콜, 평균분자량 200∼6,000(의약 부외품 원료 규격 2006 기재의 평균분자량)의 폴리에틸렌글리콜, 에틸렌글리콜 등의 다가 알코올, 소르비트, 환원전분당화물 등의 당알코올를 들 수 있고, 이들의 1종 또는 2종 이상을 사용할 수 있다(배합량은 통상, 5∼70%).Examples of the viscosifier include glycerin, propylene glycol, sugar alcohols such as polyethylene glycol, an ethylene glycol and other polyhydric alcohols having a molecular weight of 200 to 6,000 and an average molecular weight of 200 to 6,000, and sorbit, One or more of these may be used (the blending amount is usually 5 to 70%).

점결제로서는, 카티온화셀룰로스 이외의 것, 예를 들면 폴리아크릴산나트륨, 크산탄고무, 알긴산나트륨, 알긴산프로필렌글리콜에스테르, 카르복시메틸셀룰로스나트륨, 히드록시에틸셀룰로스, 카르보폴, 구아고무, 젤라틴, 아비셀 등의 유기 점결제, 몬모릴로나이트, 카올린, 벤토나이트 등의 무기 점결제를 들 수 있다(배합량은 통상, 0∼10%).Examples of the viscous liquid include those other than cationic cellulose such as sodium polyacrylate, xanthan gum, sodium alginate, propylene glycol alginate, sodium carboxymethyl cellulose, hydroxyethyl cellulose, carbopol, guar gum, gelatin, Organic montmorillonite, montmorillonite, kaolin, and bentonite (the blending amount is usually 0 to 10%).

계면활성제는, 아니온성 계면활성제로서 예를 들면 라우릴황산나트륨, 라우로일살코신나트륨, 폴리옥시에틸렌알킬황산염, N-라우로일타우린염, α-올레핀술폰산염 등, 양성 계면활성제로서 예를 들면 N-아실글루타메이트, 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인, 야자유지방산아미드프로필베타인 등, 비이온성 계면활성제로서 예를 들면 알킬글리코시드, 자당지방산에스테르, 알킬올아마이드, 폴리옥시에틸렌소르비탄모노스테아레이트, 폴리옥시에틸렌폴리옥시프로필렌글리콜, 폴리옥시에틸렌알킬에테르, 라우린산데카글리세릴, 폴리옥시에틸렌경화피마자유 등을 들 수 있다(배합량은 통상, 0.1∼5%).Examples of the surfactant include amphoteric surfactants such as sodium lauryl sulfate, lauroyl sarcosine sodium, polyoxyethylene alkyl sulfate, N-lauroyl taurine salt and? -Olefin sulfonate, N-acyl glutamate, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, and palm oil fatty acid amide propyl betaine. Examples of the nonionic surfactant include alkyl glycosides, sucrose fatty acid esters, Polyoxyethylene sorbitan monostearate, polyoxyethylene polyoxypropylene glycol, polyoxyethylene alkyl ether, lauric acid decaglyceryl, and polyoxyethylene hydrogenated castor oil (the amount of the compound is usually 0.01 to 10 parts by weight, 0.1 to 5%).

감미제로서는, 사카린트륨, 아스파르탐, 스테비오사이드, 스테비아엑기스, 파라메톡시신나믹알데히드, 네오헤스페리딘디히드로칼콘, 페릴라르틴, 방부제로서는, 에틸파라벤, 부틸파라벤 등의 파라벤(파라옥시안식향산에스테르), 안식향산나트륨을 들 수 있다. 착색제로서는, 청색1호, 황색4호, 녹색3호가 예시된다.Examples of the sweetening agent include paraffin (paroxybenzoic acid ester) such as saccharin, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neoheperidin dihydrochalcone, perylate, and preservatives such as ethylparaben, butylparaben, , And sodium benzoate. Examples of the colorant include blue No. 1, yellow No. 4, and green No. 3.

향료는, (D)성분에 더하여, 그 밖의 치마제 조성물용으로서 일반적인 임의의 향료 성분을 배합할 수 있다. 향료로서는, 적어도 멘톨 및/또는 카르본을 포함한 향료가 바람직하고, 이들을 조성물 중에 0.01∼1%의 범위에서 함유하는 것이 바람직하다.In addition to the component (D), the perfume can be blended with any other perfume ingredient common for other dentifrice compositions. As the perfume, perfumes containing at least menthol and / or carboxy are preferable, and they are preferably contained in the composition in the range of 0.01 to 1%.

유효 성분으로서는, 트라넥삼산 이외의 것, 예를 들면, 불화나트륨, 불화칼륨, 불화제1주석, 불화스트론튬, 모노플루오로인산나트륨 등의 불화물 ; 정인산의 칼륨염, 나트륨염등의 수용성 인산 화합물 ; 입실론-아미노카프론산, 알란토인클로르히드록시알미니움, 히노기티올, 아스코르빈산, 아세트산dl-토코페롤, 디히드로콜레스테롤, α-비사볼롤, 클로르헥시딘염류, 아줄렌, 글리시레틴, 글리시레틴산이나, 구리클로로필린나트륨, 클로로필, 글리세로포스페이트 등의 키레이트성 인산 화합물 ; 글루콘산구리 등의 구리 화합물 ; 염화스트론튬, 질산칼륨, 히드록삼산 또는 그 유도체, 트리폴리인산나트륨, 제올라이트, 메톡시에틸렌, 에피디히드로콜레스테린, 염화벤제토늄, 디히드로콜레스테롤, 트리클로로카르바닐리드, 구연산아연, 산화아연, 당위연(軟)엑기스, 황백엑기스, 나아가서는, 카밀레, 정자, 로즈마리, 황금, 홍화 등의 식물 추출물을 들 수 있다. 또한, 이들 유효 성분의 배합량은, 본 발명의 효과를 방해하지 않는 범위에서 유효량으로 할 수 있다.Examples of the effective ingredient include those other than tranexamic acid, for example, fluorides such as sodium fluoride, potassium fluoride, 1 tin fluoride, strontium fluoride, and sodium monofluorophosphate; Soluble phosphoric acid compounds such as potassium salts and sodium salts of orthophosphoric acid; But are not limited to, epsilon-aminocaproic acid, allantoin chlorohydroxyammini, hinokin thiol, ascorbic acid, dl-tocopherol acetate, dihydrocholesterol, a-bisabolol, chlorhexidine salts, azulene, glycyrrhetin, glycyrrhetinic acid Or a chiral phosphate compound such as copper chlorophyllin sodium, chlorophyll, glycerophosphate and the like; Copper compounds such as copper gluconate; But are not limited to, sodium chloride, strontium chloride, potassium nitrate, hydroxamic acid or a derivative thereof, sodium tripolyphosphate, zeolite, methoxyethylene, epidihydrocholesterine, benzethonium chloride, dihydrocholesterol, trichlorocarbonylide, zinc citrate, zinc oxide, (Soft) extract, yellowish white extract, and furthermore, plant extracts such as camomile, sperm, rosemary, golden, and safflower. The blending amount of these effective ingredients can be an effective amount within a range not hindering the effect of the present invention.

또한, 본 발명의 구강용 조성물의 변색 억제 방법은, (A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)를 질량비로서 0.5∼200, 또한 (B)/(C)를 질량비로서 0.2∼100으로 하는 것을 특징으로 한다. 또한, 배합 성분이나 그 배합량, 량비(量比) 등의 상세는, 상기한 바와 마찬가지이다.The method for inhibiting discoloration of an oral composition of the present invention is a method for inhibiting discoloration of an oral composition comprising (C) a tea extract and (A) + ((A)) an antioxidant in an oral composition comprising (A) a tranexamic acid and B)] / (C) in a mass ratio of 0.5 to 200, and (B) / (C) in a mass ratio of 0.2 to 100. Further, the details of the compounding ingredients, the amount thereof, the amount ratio (amount ratio) and the like are the same as those described above.

[실시례][Example]

이하, 실시례 및 비교례를 나타내고, 본 발명을 구체적으로 설명하지만, 본 발명은 하기한 실시례로 제한되는 것이 아니다. 또한, 하기한 예에서 %는 특히 단서가 없는 한 모두 질량%를 나타낸다.Hereinafter, examples and comparative examples will be shown and the present invention will be described in detail, but the present invention is not limited to the following examples. In the following examples,% represents mass% unless otherwise specified.

[실시례, 비교례][Practical example, comparative example]

표 1∼5에 표시하는 조성의 치마제(련치마) 또는 세구제를 일상 방법에 의해 조제하고, 이들을 시험 조성물로 하여 하기 방법으로 평가하였다. 결과를 표에 병기하였다.A skirt (skirt) or scouring agent having the compositions shown in Tables 1 to 5 was prepared by a routine method, and these were evaluated as the test composition by the following method. The results are listed in the table.

(1) 외관 안정성(변색 억제 효과)의 평가 방법(1) Evaluation method of appearance stability (discoloration inhibiting effect)

시험 조성물의 치마제는 라미네이트 튜브에, 세구제는 플라스틱 병에 충전하고, 제조 직후의 외관 및 50℃ 환경하에서 3개월간 보관 후의 외관을 각각 육안으로 확인하고, 하기한 평가 기준에 의거하여 변색에 관해 평가하였다. ○ 또는 ◎의 평가가 확보된 것을, 변색이 인정되지 않는 외관 안정성이 좋은 시험 조성물이라고 판단하였다.The appearance of the test composition immediately after the preparation and the appearance after storage for 3 months under an environment of 50 캜 were visually confirmed by visual inspection, and on the basis of the following evaluation criteria, Respectively. ? Or? Was judged to be a test composition having good appearance stability without discoloration.

평가 기준 :Evaluation standard :

◎ : 변색이 인정되지 않는다◎: discoloration is not recognized

○ : 변색이 약간 인정되지만, 문제 없는 레벨이다○: Discoloration is slightly recognized, but problem-free level

△ : 변색이 인정된다?: Discoloration is recognized

× : 변색이 현저하게 인정된다.X: Discoloration was recognized remarkably.

(2) 불쾌한 맛의 뒷맛 없음(불쾌한 맛 개선 효과)의 평가 방법(2) Evaluation method of unpleasant aftertaste (unpleasant taste improving effect)

피험자로서 전문 패널러 10인을 이용하여 시험 조성물을 관능 평가하였다.The test composition was subjected to sensory evaluation by using a professional panelist 10 as a subject.

치마제는, 라미네이트 튜브에 충전한 치마제 조성물을 칫솔 위에 약 1g 압출하여 싣고, 평소와 같은 방법으로 3분간 이닦기하고, 또한, 세구제는, 약 10㎖을 약 20초간 입에 머금고, 토출하여 사용하였다. 사용하고 10분 경과 후의 입안에 남는 불쾌한 맛에 관해, 하기한 평점 기준에 의거하여 평가하였다.The dentifrice was prepared by extruding a dentifrice composition filled in a laminate tube onto a toothbrush and extruding the dentifrice composition onto the toothbrush for 3 minutes in the same manner as usual. The dentifrice was filled with about 10 ml for about 20 seconds, Respectively. The unpleasant taste remaining in the mouth after 10 minutes of use was evaluated based on the following rating criteria.

평점 기준 :Rated by:

1점 : 불쾌한 맛을 매우 느낀다1 point: I feel very unpleasant taste.

2점 : 불쾌한 맛을 느낀다2 points: I feel unpleasant taste

3점 : 불쾌한 맛을 약간 느끼지만, 문제 없는 레벨이다3 points: I feel a bit of an unpleasant taste, but it is a problem-free level

4점 : 불쾌한 맛을 전혀 느끼지 않는다4 points: I do not feel any unpleasant taste at all

전문 패널러 10인이 평가한 결과를 평균한 값을 산출하고, 하기한 평가 기준에 의거하여 평가하였다. The average value of the results of the evaluation by the 10 professional panelists was calculated and evaluated based on the following evaluation criteria.

☆, ◎ 및 ○의 평가가 확보된 것을, 사용 후에 불쾌한 맛의 뒷맛이 느껴지지 않는 시험 조성물이라고 판단하였다., &Amp; cir &, and & cir & were secured, and it was judged that the test composition did not feel unpleasant aftertaste after use.

평가 기준 :Evaluation standard :

☆ : 평균점 4점☆: Average point 4 points

◎ : 평균점 3.5점 이상 4.0점 미만◎: Average point 3.5 points or more and less than 4.0 points

○ : 평균점 3.0점 이상 3.5점 미만○: 3.0 points or more and less than 3.5 points

△ : 평균점 2.0점 이상 3.0점 미만△: Average point of 2.0 points or more and less than 3.0 points

× : 평균점 1.0점 이상 2.0점 미만X: Average point is 1.0 or more and less than 2.0 point

사용 원료의 상세를 하기에 나타낸다.Details of the raw materials used are shown below.

(A) 트라넥삼산 : 시믹CMO(주)제(A) Tranexamic acid: manufactured by Shimik CMO Co., Ltd.

(B) 카티온화셀룰로스 :(B) Cationic Cellulose:

상품명 : 셀코트 L-200, 악조노벨(주)제Trade name: Cellcoat L-200, manufactured by Akzo Nobel Co., Ltd.

(C) 차엑기스(C) Tea extract

녹차 추출물, 상품명 「화(和)ism」, 엑기스분 0.2%, 용매 : 50% 부틸렌글리콜 수용액, 마루젠제약(주)제Green tea extract, trade name " ism, " 0.2% extract, solvent: 50% butylene glycol aqueous solution,

(D) 3-옥탄올 시오노향료(주)제(D) 3-octanoloxy perfume

(D) 3-옥틸아세테이트 : (주)이노우에 향료제조소제(D) 3-octyl acetate: manufactured by Inoue Flavor Manufacture Co., Ltd.

(D) 3-옥탄온 : (주)이노우에 향료제조소제(D) 3-Octanone: manufactured by Inoue Flavor Manufacture Co., Ltd.

(D) 펜콘 : 코에이흥업(주)제 또한,(D) Pencon: manufactured by Koei Kogyo Co., Ltd. Also,

사용한 향료A의 조성은 하기와 같다.The composition of the perfume A used is as follows.

향료A의 조성 :Composition of perfume A:

카르본 20%Carbon 20%

l-멘톨 66l-menthol 66

메틸부탄알 5Methyl butanal 5

시트로네랄 2Citronellal 2

페릴알데하이드 2Perylaldehyde 2

운데센알 1Unsensual 1

리날로올 0.5Linalool 0.5

오렌지유 0.5Orange oil 0.5

에탄올 3Ethanol 3

합계 100%Total 100%

[표 1][Table 1]

Figure pat00001
Figure pat00001

* ; (C)성분의 배합량은 차엑기스의 순분량을 나타낸다(이하 동일).*; (C) represents the net amount of tea extract (hereinafter the same).

[표 2][Table 2]

Figure pat00002
Figure pat00002

[표 3][Table 3]

Figure pat00003
Figure pat00003

[표 4][Table 4]

Figure pat00004
Figure pat00004

[표 5][Table 5]

Figure pat00005
Figure pat00005

Claims (7)

(A) 트라넥삼산,
(B) 카티온화셀룰로스 및
(C) 차엑기스를 함유하고, [(A)+(B)]/(C)가 질량비로서 0.5∼200, 또한 (B)/(C)가 질량비로서 0.2∼100인 것을 특징으로 하는 구강용 조성물.
(A) Tranexamic acid,
(B) cationic cellulose and
(B) / (C) is in a mass ratio of 0.5 to 200, and (B) / (C) is in a mass ratio of 0.2 to 100, Composition.
제1항에 있어서
(B) 카티온화셀룰로스가, 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드인 것을 특징으로 하는 구강용 조성물.
The method of claim 1, wherein
(B) the cationic cellulose is hydroxyethyl cellulose dimethyldiallylammonium chloride.
제1항 또는 제2항에 있어서
(A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 엑기스 순분으로서 0.0005∼0.2질량% 함유하는 것을 특징으로 하는 구강용 조성물.
The method according to claim 1 or 2, wherein
Wherein the composition contains 0.01 to 0.2 mass% of component (A), 0.01 to 0.2 mass% of component (B), and 0.0005 to 0.2 mass% of component (C) as pure pure extract.
제1항 내지 제3항 중 어느 한 항에 있어서
또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 이상을 0.0001∼0.1질량% 함유하는 것을 특징으로 하는 구강용 조성물.
4. The method according to any one of claims 1 to 3, wherein
Further, the composition for oral use is characterized by containing at least 0.0001 to 0.1 mass% of at least one selected from (D) 3-octanol, 3-octyl acetate, 3-octanone and ficcon.
제1항 내지 제4항 중 어느 한 항에 있어서
치마제 또는 세구제인 것을 특징으로 하는 구강용 조성물.
The method according to any one of claims 1 to 4, wherein
Wherein the oral composition is a cosmetic or dermatological agent.
(A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)를 질량비로서 0.5∼200, 또한 (B)/(C)를 질량비로서 0.2∼100으로 하는 것을 특징으로 하는 상기 구강용 조성물의 변색 억제 방법.(A) + (B)] / (C) in a mass ratio of 0.5 to 200, and (B) / (C) in an oral composition containing (A) And (B) / (C) in a weight ratio of 0.2 to 100. 제6항에 있어서
(A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 엑기스 순분으로서 0.0005∼0.2질량% 배합하는 것을 특징으로 하는 상기 구강용 조성물의 변색 억제 방법.
The method of claim 6, wherein
(B) is contained in an amount of 0.01 to 0.2% by mass, and the component (C) is added in an amount of 0.0005 to 0.2% by mass as pure extract of the extract.
KR1020180112642A 2017-12-22 2018-09-20 Oral composition and method for inhibiting discoloration thereof KR102531788B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP-P-2017-245754 2017-12-22
JP2017245754A JP2019112329A (en) 2017-12-22 2017-12-22 Oral cavity composition and discoloration suppression method thereof

Publications (2)

Publication Number Publication Date
KR20190076829A true KR20190076829A (en) 2019-07-02
KR102531788B1 KR102531788B1 (en) 2023-05-16

Family

ID=67023301

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180112642A KR102531788B1 (en) 2017-12-22 2018-09-20 Oral composition and method for inhibiting discoloration thereof

Country Status (3)

Country Link
JP (1) JP2019112329A (en)
KR (1) KR102531788B1 (en)
CN (1) CN109953897B (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842565B2 (en) 1979-04-27 1983-09-20 株式会社 愛知電機工作所 Switching switch for tap switching device on load
JPS60130509A (en) 1983-12-20 1985-07-12 Lion Corp Composition for oral cavity
JP2001226244A (en) 1999-12-08 2001-08-21 Lion Corp Tooth paste composition
JP2002212042A (en) * 2001-01-19 2002-07-31 Pacific Corp Method for producing plant extract powder and composition for oral cavity containing plant extract powder produced by the method
KR100450391B1 (en) * 1996-07-03 2005-04-22 주식회사 엘지생활건강 Toothpaste Composition
JP2008143870A (en) 2006-12-13 2008-06-26 Lion Corp Oral composition
JP2009149565A (en) 2007-12-21 2009-07-09 Lion Corp Dentifrice composition
JP4656299B2 (en) 2004-12-24 2011-03-23 ライオン株式会社 Dentifrice composition and method for preventing discoloration of ε-aminocaproic acid and / or tranexamic acid-containing dentifrice composition
KR20110060462A (en) * 2009-11-30 2011-06-08 (주)아모레퍼시픽 Preventive composition of color change for natural pigment
KR20120086685A (en) * 2009-11-06 2012-08-03 라이온 가부시키가이샤 Dentifrice composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS595109A (en) * 1982-06-30 1984-01-12 Lion Corp Composition for oral cavity
JP2000297022A (en) * 1999-04-12 2000-10-24 Lion Corp Composition for oral cavity
JP5597969B2 (en) * 2009-11-06 2014-10-01 ライオン株式会社 Dentifrice composition
WO2012171738A1 (en) * 2011-06-17 2012-12-20 Unilever N.V. An oral care composition

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842565B2 (en) 1979-04-27 1983-09-20 株式会社 愛知電機工作所 Switching switch for tap switching device on load
JPS60130509A (en) 1983-12-20 1985-07-12 Lion Corp Composition for oral cavity
KR100450391B1 (en) * 1996-07-03 2005-04-22 주식회사 엘지생활건강 Toothpaste Composition
JP2001226244A (en) 1999-12-08 2001-08-21 Lion Corp Tooth paste composition
JP2002212042A (en) * 2001-01-19 2002-07-31 Pacific Corp Method for producing plant extract powder and composition for oral cavity containing plant extract powder produced by the method
JP4656299B2 (en) 2004-12-24 2011-03-23 ライオン株式会社 Dentifrice composition and method for preventing discoloration of ε-aminocaproic acid and / or tranexamic acid-containing dentifrice composition
JP2008143870A (en) 2006-12-13 2008-06-26 Lion Corp Oral composition
JP2009149565A (en) 2007-12-21 2009-07-09 Lion Corp Dentifrice composition
KR20120086685A (en) * 2009-11-06 2012-08-03 라이온 가부시키가이샤 Dentifrice composition
KR20110060462A (en) * 2009-11-30 2011-06-08 (주)아모레퍼시픽 Preventive composition of color change for natural pigment

Also Published As

Publication number Publication date
KR102531788B1 (en) 2023-05-16
CN109953897A (en) 2019-07-02
CN109953897B (en) 2023-04-25
JP2019112329A (en) 2019-07-11

Similar Documents

Publication Publication Date Title
JP5251350B2 (en) Dentifrice composition
JP5874383B2 (en) Oral composition
WO2011055709A1 (en) Dentifrice composition
JP5672651B2 (en) Mouthwash composition
KR102454653B1 (en) Composition for use in oral cavity
KR101980563B1 (en) Tooth paste composition
KR101624764B1 (en) Dentifrice composition
JP2020011951A (en) Oral composition
JP7447470B2 (en) dentifrice composition
WO2018066341A1 (en) Oral composition and method for suppressing discoloration of formulation and liquid separation thereof
JP2015117215A (en) Dentifrice composition
JP5825088B2 (en) Liquid oral composition
CN111902125B (en) Oral composition and bitterness improver of alpha-olefin sulfonate
JP5600872B2 (en) Toothpaste composition
JP6409618B2 (en) Dentifrice composition
JP3582571B2 (en) Oral liquid preparation
KR20190076829A (en) Oral composition and method for inhibiting discoloration thereof
KR20180133220A (en) Oral composition
WO2019107340A1 (en) Composition for oral use
JP7371351B2 (en) Oral composition
JP2018203714A (en) Oral composition
WO2016136719A1 (en) Toothpaste composition
KR20240042359A (en) Dentistry composition
CN117693331A (en) Liquid oral composition
JP2023005325A (en) oral composition

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant